ERB-257

DRUG2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Healthy Subjects

Phase 1

Study Evaluating the Safety and Pharmacokinetics (PK) of Ascending Single IV Doses of ERB-257 in Healthy Japanese Males

CompletedNCT00722202

Wyeth is now a wholly owned subsidiary of PfizerHealthy Subjects

Start: 2008-10-31End: 2008-11-30Updated: 2009-04-28

Study Evaluating the Safety and Pharmacokinetics of Ascending Single IV Doses of ERB-257

CompletedNCT00722501

Wyeth is now a wholly owned subsidiary of PfizerHealthy Subjects

Start: 2008-08-31End: 2008-11-30Updated: 2009-04-28